Boardroom Alpha
Boardroom Alpha
LXFR · Current Report (Form 8-K) · Filed June 12, 2026

Luxfer Holdings PLC — Current Report (Form 8-K)

Form
8-K
Filed
June 12, 2026
Period
Jun 11, 2026
Ticker
LXFR
Accession
0001437749-26-020383
Boardroom Alpha · Filing insights

Shareholders elected directors and approved executive compensation. They ratified PwC, authorized 20% share issuance with waived preemptive rights, and set annual say-on-pay.

About Luxfer Holdings PLC
Market cap
$460M
1Y TSR
+41.5%
3Y TSR
+17.8%
Board grade
B-
Sector
Industrials
CEO
Andrew Butcher
Last annual meeting: Jun 11, 2026 · View full Luxfer Holdings PLC profile →
lxfr20260611_8k.htm
 
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
______________________________________________
 
FORM 8-K
______________________________________________
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the
 
Securities Exchange Act of 1934
 
Date of Report (Date of Earliest Event Reported):  June 11, 2026
______________________________________________
 
Luxfer Holdings PLC
__________________________
(Name of Registrant as Specified in Charter)
 
England and Wales
001-35370
98-1024030
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
 
3016 Kansas Avenue,
Riverside, CA, 92507
(Address and Zip Code of Principal Executive Offices)
Registrant’s Telephone Number, including Area Code: +1 414-269-2419
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Ordinary Shares, nominal value £0.50 each
LXFR
New York Stock Exchange
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
 
 

 
Section 5         Corporate Governance and Management
 
Item 5.07 Submission of Matters to a Vote of Security Holders.
 
The Company held its 2026 AGM on Thursday, June 11, 2026, in Manchester, England. There were 27,006,409 ordinary shares issued and outstanding at the close of business on April 17, 2026, the voting record date, which were entitled to receive notice of, and vote at, the AGM. Holders of 24,297,754 ordinary shares (90.0%) were represented in person or by proxy at the AGM, constituting a quorum.
 
At the AGM, the Company’s shareholders voted on fourteen resolutions; each of which is described in detail on pages 14-23 of the Proxy Statement. The number of votes cast for or against, and the number of abstentions and any non-votes, with respect to each resolution are set forth below. The results detailed below represent final voting results.
 
Ordinary Resolutions 1-7: Election of Directors
 
The nominees listed below were elected to serve as Directors of the Company for a one year term, expiring on completion of the 2027 Annual General Meeting of Shareholders.
 
Nominee
Votes For
Votes Against
Abstentions
Non-Votes
Andy Butcher
 22,497,143
 78,822
 2,687
 1,719,102
Patrick Mullen
 22,295,622
 280,344
2,686
1,719,102
Clive Snowdon
21,816,453
 759,512
2,687
1,719,102
Lisa Trimberger
22,370,404
 205,662
 2,586
1,719,102
Richard Hipple
22,171,423
 404,547
 2,682
1,719,102
Stewart Watson
22,496,152
 79,613
 2,887
 1,719,102
Sylvia A. Stein
22,301,829
 272,042
 4,781
 1,719,102
 
Ordinary Resolution 8: Approval of the Directors Remuneration Report
 
The Company’s shareholders approved the Directors’ Remuneration Report for the year ended December 31, 2025
 
Votes For
Votes Against
Abstentions
Non-Votes
21,502,968
548,112
527,572
1,719,102
 
Ordinary Resolution 9: Approval of Executive Compensation
 
The Company’s shareholders approved, by non-binding advisory vote, that the compensation of the Company’s Named Executive Officers for the year ended December 31, 2025 be approved.
 
Votes For
Votes Against
Abstentions
Non Votes
21,501,896
551,982
524,774
1,719,102
 
Ordinary Resolution 10: Frequency of say-on-pay votes
 
On a non-binding advisory basis, the Company’s shareholders voted to hold a “say-on-pay” vote on the compensation of the Company’s Named Executive Officers every 1 year, consistent with the recommendation of the Board of Directors (the “Board”).
 
Votes for Every 1 Year
Votes for Every 2 Years
Votes for Every 3 Years
Abstentions
Non Votes
21,569,645
2,795
994,820
11,392
1,719,102
 
In light of the results of this vote and other factors, on June 11, 2026, the Board resolved that it would hold an advisory vote on the compensation of its Named Executive Officers every 1 year until the Company holds the next shareholder advisory vote on the frequency of “say-on-pay” votes, which shall be no later than the Company’s 2027 Annual General Meeting of Shareholders.
 
Ordinary Resolution 11: Ratification of the re-appointment of PricewaterhouseCoopers LLP as the independent auditor of the Company until conclusion of the 2027 Annual General Meeting
 
The Company’s shareholders ratified the re-appointment of PricewaterhouseCoopers LLP as the independent auditor of the Company until conclusion of the 2027 Annual General Meeting.
 
Votes For
Votes Against
Abstentions
Non-Votes
23,224,484
1,067,255
6,015
 
Ordinary Resolution 12: Authorization of the Audit Committee to set the independent auditors remuneration
 
The Company’s shareholders authorized the Audit Committee to set the remuneration of PricewaterhouseCoopers LLP as the Company’s independent auditor.
 
Votes For
Votes Against
Abstentions
Non-Votes
24,280,164
12,626
4,964
 
Special Resolution 13: Authorization of the Board of Directors to issue shares and to grant rights to subscribe for or convert securities into shares
 
The Board of Directors be generally and unconditionally authorized, for the purposes of section 551 of the Companies Act, to exercise all powers of the Company to issue shares in the Company and to grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of $70,739,136, which is equivalent to 20% of the Company’s issued share capital as of April 1, 2026, to such persons and at such times and on such terms as the Directors think proper, provided that this authority shall, unless renewed, varied, or revoked by the Company, expire upon conclusion of the next Annual General Meeting of the Company
 
Votes For
Votes Against
Abstentions
Non-Votes
23,679,176
609,041
9,537
 
 
 

 
 
Special Resolution 14: Authorization of the Board of Directors to disapply preemptive rights to equity securities issued or sold for cash
 
The Company’s shareholders authorized the Board of Directors be generally authorized, in accordance with sections 570 and 573 of the Companies Act, to issue equity securities (as defined in section 560 of the Companies Act) for cash, pursuant to the authority conferred on the Board by Resolution 13 above, and/or to sell ordinary shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash, in each case as if section 561 of the Companies Act did not apply to any such issuance or sale. This power shall be limited to the issuance of equity securities or sale of treasury shares up to an aggregate nominal amount of $17,684,784 and shall expire upon conclusion of the 2027 Annual General Meeting.
 
Votes For
Votes Against
Abstentions
Non-Votes
24,151,541
139,175
7,038
 
Section 9 Financial Statements and Exhibits Item 9.01 Financial Statements and Exhibits.
 
(d)         Exhibits
 
Exhibit
Number         Description
 
104         Interactive Data File (Inline XRBL tagging embedded within Cover Page of this Current Report on Form 8-K)
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
Luxfer Holdings PLC
(Registrant)
 
 
 
Date: June 12, 2026
 
 
   By: /s/ Benjamin M. Coulson Name: Benjamin M. Coulson
Title: Corporate Controller & Company Secretary
 
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Luxfer Holdings PLC (LXFR)

Reference

Frequently asked questions

When did Luxfer Holdings PLC file this 8-K?
Luxfer Holdings PLC (LXFR) filed this Current Report (Form 8-K) with the SEC on June 12, 2026. The accession number assigned by EDGAR is 0001437749-26-020383.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Shareholders elected directors and approved executive compensation. They ratified PwC, authorized 20% share issuance with waived preemptive rights, and set annual say-on-pay. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Luxfer Holdings PLC's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Luxfer Holdings PLC has filed under CIK 1096056, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer